Institute of Biotechnology in Plant Production (IFA-Tulln), University of Natural Resources and Life Sciences Vienna, 3430 Tulln, Austria.
PGSB Plant Genome and Systems Biology, Helmholtz Center Munich, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Genes (Basel). 2021 Jan 19;12(1):114. doi: 10.3390/genes12010114.
Genomic selection with genome-wide distributed molecular markers has evolved into a well-implemented tool in many breeding programs during the last decade. The resistance against Fusarium head blight (FHB) in wheat is probably one of the most thoroughly studied systems within this framework. Aside from the genome, other biological strata like the transcriptome have likewise shown some potential in predictive breeding strategies but have not yet been investigated for the FHB-wheat pathosystem. The aims of this study were thus to compare the potential of genomic with transcriptomic prediction, and to assess the merit of blending incomplete transcriptomic with complete genomic data by the single-step method. A substantial advantage of gene expression data over molecular markers has been observed for the prediction of FHB resistance in the studied diversity panel of breeding lines and released cultivars. An increase in prediction ability was likewise found for the single-step predictions, although this can mostly be attributed to an increased accuracy among the RNA-sequenced genotypes. The usage of transcriptomics can thus be seen as a complement to already established predictive breeding pipelines with pedigree and genomic data, particularly when more cost-efficient multiplexing techniques for RNA-sequencing will become more accessible in the future.
在过去十年中,利用基因组范围内分布的分子标记进行基因组选择已经发展成为许多育种计划中一种实施良好的工具。在这个框架内,小麦对赤霉病(FHB)的抗性可能是研究最透彻的系统之一。除了基因组,转录组等其他生物层次也在预测性育种策略中显示出了一些潜力,但尚未针对 FHB-小麦病理系统进行研究。因此,本研究的目的是比较基因组预测和转录组预测的潜力,并通过单步法评估不完全转录组与完整基因组数据混合的优点。在研究的育种系和已发布品种的多样性面板中,基因表达数据在预测 FHB 抗性方面表现出了优于分子标记的显著优势。单步预测也发现了预测能力的提高,尽管这主要归因于 RNA 测序基因型的准确性提高。因此,转录组学的使用可以被视为对基于系谱和基因组数据的已有预测性育种管道的补充,特别是当未来更具成本效益的 RNA-seq 多重技术更容易获得时。